Besides, EMMPRIN has been shown to promote tumor growth in an anchorage-dependent manner by inducing hyaluronan production (27), and to stimulate cancer cell proliferation via the activation of ERK1/2 and p38 MAPK signaling pathways (28). The gene discussed is MAPK3; the disease is neoplasm.